Evidence map›Paper›PMID 31184711›Full record

ArticleEndocrinology2019

Dihydrotestosterone Increases Cytotoxic Activity of Macrophages on Prostate Cancer Cells via TRAIL.

Geun Taek Lee, Jeong Hyun Kim, Seok Joo Kwon, Mark N Stein, Jeong Hee Hong, Naoya Nagaya, Sachin Billakanti, Melina Minji Kim, Wun-Jae Kim, Isaac Yi Kim

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. A Novel Erinacine S Derivative fromInternational journal of medical sciences · 2025
    Article
  7. Review
  8. RISING STARS: Androgens and immune cell function.The Journal of endocrinology · 2024
    Review
  9. Article
  10. Gender-Specific Impact of Sex Hormones on the Immune System.International journal of molecular sciences · 2023
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Geun Taek LeeSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Jeong Hyun KimSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Seok Joo KwonSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Mark N SteinSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Jeong Hee HongSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Naoya NagayaSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Sachin BillakantiSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Melina Minji KimSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Wun-Jae KimDepartment of Urology, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.
Isaac Yi KimSection of Urologic Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
Rutgers, The State University of New Jersey · USChungbuk National University · KR

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Chang S Chan · 1997 to 2026
$94.5M
NCI NIH HHS P30 CA072720
6 · The paper itself

Abstract

Although androgen deprivation therapy (ADT) and immunotherapy are potential treatment options in men with metastatic prostate cancer (CaP), androgen has conventionally been proposed to be a suppressor of the immune response. However, we herein report that DHT activates macrophages. When the murine macrophage cell line (RAW 264.7), human monocyte cell line (THP-1), and human peripheral blood monocytes were cultured with androgen-resistant CaP cell lines, DHT increased cytotoxicity of macrophages in a concentration-dependent manner. Further studies revealed that DHT induced M1 polarization and increased the expression levels of TNF-related apoptosis-inducing ligand (TRAIL) in macrophages and that this effect was abrogated when TRAIL was neutralized with a blocking antibody or small interfering RNA. Subsequent experiments demonstrated that induction of TRAIL expression was regulated by direct binding of androgen receptor to the TRAIL promoter region. Finally, an in vivo mouse study demonstrated that castration enhanced the growth of an androgen-resistant murine CaP tumor and that this protumorigenic effect of castration was blocked when macrophages were removed with clodronate liposomes. Collectively, these results demonstrate that DHT activates the cytotoxic activity of macrophages and suggest that immunotherapy may not be optimal when combined with ADT in CaP.

Indexed as

AnimalsCells, CulturedCytotoxicity, ImmunologicDihydrotestosteroneHumansImmunotherapyMacrophagesMaleMiceMice, Inbred C57BLProstatic NeoplasmsReceptors, AndrogenTNF-Related Apoptosis-Inducing LigandDihydrotestosteroneReceptors, AndrogenTNF-Related Apoptosis-Inducing LigandTNFSF10 protein, human

Identifiers

PMID31184711
PMCPMC6691685
OpenAlexW2949811887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.